{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:40Z","timestamp":1792783180767,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 Cattolica del Sacro Cuore","id":[{"id":"https:\/\/ror.org\/03h7r5v07","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>A previous double-blind, randomized, placebo-controlled, phase II clinical trial reported beneficial effects of a short-term treatment (10 days) with murine nerve growth factor (mNGF) eye drops on visual function in children with optic pathway gliomas (OPG). The present study aimed to evaluate long-term changes in clinical and neuroradiological parameters in the cohort of OPG patients who had previously participated in the phase II mNGF trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifteen of the 18 patients originally enrolled in the phase II mNGF trial agreed to undergo clinical and neuroradiological monitoring over a 48-month follow-up period. Of these, 9 had originally been randomized to mNGF and 6 to placebo; no additional treatment (mNGF, chemotherapy, or radiotherapy) was administered during the extended follow-up. Every 6 months, patients underwent general clinical and neuro-ophthalmological examination, visual evoked potentials (VEP), and photopic negative response of the electroretinogram (PhNR). Brain MRI was performed every 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comparison of initial and final follow-up median values revealed no statistically significant changes in visual acuity, VEP amplitude, PhNR amplitude, or visual field radius. No significant differences were observed in any parameter relative to baseline values of the mNGF trial. Brain MRI demonstrated stable disease in all patients throughout the observation period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings, obtained in an observational extension of the original randomized cohort, indicate favorable long-term safety and tolerability of a short-term course of topical mNGF in children with OPG, with sustained visual and neuroradiological stability over four years, rather than evidence of persistent treatment efficacy. Further prospective, adequately powered and randomized clinical studies are needed to confirm both the short- and long-term clinical efficacy of NGF treatment in preventing OPG-induced visual loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-026-05777-z","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:36:26Z","timestamp":1788276986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children"],"prefix":"10.1007","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-3511","authenticated-orcid":false,"given":"Antonio","family":"Ruggiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Attin\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Verdolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Falsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"3","key":"5777_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ICU.0000000000000370","volume":"28","author":"N Rasool","year":"2017","unstructured":"Rasool N, Odel JG, Kazim M (2017) Optic pathway glioma of childhood. Curr Opin Ophthalmol 28(3):289\u2013295. https:\/\/doi.org\/10.1097\/ICU.0000000000000370","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"5777_CR2","doi-asserted-by":"publisher","first-page":"e26838","DOI":"10.1002\/pbc.26838","volume":"65","author":"S Khatua","year":"2018","unstructured":"Khatua S, Gutmann DH, Packer RJ (2018) Neurofibromatosis type 1 and optic pathway glioma: molecular interplay and therapeutic insights. Pediatr Blood Cancer 65(3):e26838. https:\/\/doi.org\/10.1002\/pbc.26838","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"5777_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2217\/cns.12.47","volume":"2","author":"I Fried","year":"2013","unstructured":"Fried I, Tabori U, Tihan T, Reginald A, Bouffet E (2013) Optic pathway gliomas: a review. CNS Oncol 2(2):143\u2013159. https:\/\/doi.org\/10.2217\/cns.12.47","journal-title":"CNS Oncol"},{"issue":"12","key":"5777_CR4","doi-asserted-by":"publisher","first-page":"e27377","DOI":"10.1002\/pbc.27377","volume":"65","author":"B Sturgess","year":"2018","unstructured":"Sturgess B, Brown M, Fraser F, Bailey S (2018) A qualitative study of the multi-professional team approach to the management of children with optic pathway gliomas. Pediatr Blood Cancer 65(12):e27377. https:\/\/doi.org\/10.1002\/pbc.27377","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"5777_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ajo.2015.07.036","volume":"160","author":"RA Avery","year":"2015","unstructured":"Avery RA, Cnaan A, Schuman JS et al (2015) Longitudinal change of circumpapillary retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol 160(5):944\u2013952e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.07.036","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"5777_CR6","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/neuonc\/noab138","volume":"23","author":"T Milde","year":"2021","unstructured":"Milde T, Rodriguez FJ, Barnholtz-Sloan JS et al (2021) Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas. Neuro Oncol 23(10):1634\u20131646. https:\/\/doi.org\/10.1093\/neuonc\/noab138","journal-title":"Neuro Oncol"},{"issue":"41","key":"5777_CR7","doi-asserted-by":"publisher","first-page":"14087","DOI":"10.1523\/JNEUROSCI.3242-12.2012","volume":"32","author":"DH Gutmann","year":"2012","unstructured":"Gutmann DH, Parada LF, Silva AJ, Ratner N (2012) Neurofibromatosis type 1: modeling CNS dysfunction. J Neurosci 32(41):14087\u201314093. https:\/\/doi.org\/10.1523\/JNEUROSCI.3242-12.2012","journal-title":"J Neurosci"},{"issue":"6","key":"5777_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/neuonc\/now267","volume":"19","author":"JA Toonen","year":"2017","unstructured":"Toonen JA, Ma Y, Gutmann DH (2017) Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction. Neuro Oncol 19(6):808\u2013819. https:\/\/doi.org\/10.1093\/neuonc\/now267","journal-title":"Neuro Oncol"},{"issue":"4","key":"5777_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/WNO.0b013e3182745600","volume":"32","author":"V Porciatti","year":"2012","unstructured":"Porciatti V, Ventura LM (2012) Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J Neuroophthalmol 32(4):354\u2013358. https:\/\/doi.org\/10.1097\/WNO.0b013e3182745600","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"5777_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1523\/JNEUROSCI.09-04-01263.1989","volume":"9","author":"G Carmignoto","year":"1989","unstructured":"Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C (1989) Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 9(4):1263\u20131272. https:\/\/doi.org\/10.1523\/JNEUROSCI.09-04-01263.1989","journal-title":"J Neurosci"},{"issue":"6","key":"5777_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cytogfr.2004.09.003","volume":"15","author":"A Micera","year":"2004","unstructured":"Micera A, Lambiase A, Aloe L et al (2004) Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev 15(6):411\u2013417. https:\/\/doi.org\/10.1016\/j.cytogfr.2004.09.003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"5777_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s12035-018-1154-1","volume":"56","author":"LA Mesentier-Louro","year":"2019","unstructured":"Mesentier-Louro LA, Rosso P, Carito V et al (2019) Nerve growth factor role on retinal ganglion cell survival and axon regrowth: effects of ocular administration in experimental models of optic nerve injury. Mol Neurobiol 56(2):1056\u20131069. https:\/\/doi.org\/10.1007\/s12035-018-1154-1","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5777_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1545968310397201","volume":"25","author":"B Falsini","year":"2011","unstructured":"Falsini B, Chiaretti A, Barone G et al (2011) Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology. Neurorehabil Neural Repair 25(6):512\u2013520. https:\/\/doi.org\/10.1177\/1545968310397201","journal-title":"Neurorehabil Neural Repair"},{"issue":"Pt 2","key":"5777_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/brain\/awv366","volume":"139","author":"B Falsini","year":"2016","unstructured":"Falsini B, Chiaretti A, Rizzo D et al (2016) Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial. Brain 139(Pt 2):404\u2013414. https:\/\/doi.org\/10.1093\/brain\/awv366","journal-title":"Brain"},{"key":"5777_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"5777_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamaophthalmol.2013.7649","volume":"132","author":"RA Avery","year":"2014","unstructured":"Avery RA, Hwang EI, Ishikawa H et al (2014) Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol 132(3):265\u2013271. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.7649","journal-title":"JAMA Ophthalmol"},{"key":"5777_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1470-2045(11)70057-2","volume":"12","author":"MJ van den Bent","year":"2011","unstructured":"van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (RANO): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583\u2013593","journal-title":"Lancet Oncol"},{"issue":"3","key":"5777_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M (2006) Visual acuities hand motion and counting fingers can be quantified with the Freiburg Visual Acuity Test. Invest Ophthalmol Vis Sci 47(3):1236\u20131240","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"21 Suppl 1","key":"5777_CR19","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1212\/01.wnl.0000435745.95155.b8","volume":"81","author":"MJ Fisher","year":"2013","unstructured":"Fisher MJ, Avery RA, Allen JC et al (2013) Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology 81(21 Suppl 1):S15\u2013S24. https:\/\/doi.org\/10.1212\/01.wnl.0000435745.95155.b8","journal-title":"Neurology"},{"issue":"6","key":"5777_CR20","doi-asserted-by":"publisher","first-page":"e0130895","DOI":"10.1371\/journal.pone.0130895","volume":"10","author":"DE Patel","year":"2015","unstructured":"Patel DE, Cumberland PM, Walters BC, Russell-Eggitt I, Rahi JS, OPTIC study group (2015) Study of Optimal Perimetric Testing in Children (OPTIC): feasibility, reliability and repeatability of perimetry in children. PLoS ONE 10(6):e0130895. https:\/\/doi.org\/10.1371\/journal.pone.0130895","journal-title":"PLoS ONE"},{"issue":"11","key":"5777_CR21","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1167\/iovs.11-8321","volume":"52","author":"AK Bittner","year":"2011","unstructured":"Bittner AK, Iftikhar MH, Dagnelie G (2011) Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa. Invest Ophthalmol Vis Sci 52(11):8042\u20138046. https:\/\/doi.org\/10.1167\/iovs.11-8321","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"5777_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0014-4886(91)90097-v","volume":"111","author":"G Carmignoto","year":"1991","unstructured":"Carmignoto G, Comelli MC, Candeo P et al (1991) Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol 111(3):302\u2013311. https:\/\/doi.org\/10.1016\/0014-4886(91)90097-v","journal-title":"Exp Neurol"},{"key":"5777_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2202-10-52","volume":"10","author":"S Sivilia","year":"2009","unstructured":"Sivilia S, Giuliani A, Fern\u00e1ndez M et al (2009) Intravitreal NGF administration counteracts retina degeneration after permanent carotid artery occlusion in rat. BMC Neurosci 10:52. https:\/\/doi.org\/10.1186\/1471-2202-10-52","journal-title":"BMC Neurosci"},{"issue":"12","key":"5777_CR24","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00417-008-0913-5","volume":"246","author":"M Coassin","year":"2008","unstructured":"Coassin M, Lambiase A, Sposato V et al (2008) Retinal p75 and Bax overexpression is associated with retinal ganglion cell apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol 246(12):1743\u20131749. https:\/\/doi.org\/10.1007\/s00417-008-0913-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"5777_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00381-004-0959-6","volume":"20","author":"A Chiaretti","year":"2004","unstructured":"Chiaretti A, Aloe L, Antonelli A et al (2004) Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas. Childs Nerv Syst 20(6):412\u2013419. https:\/\/doi.org\/10.1007\/s00381-004-0959-6","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"5777_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/a:1006127624487","volume":"41","author":"T Watanabe","year":"1999","unstructured":"Watanabe T, Katayama Y, Kimura S, Yoshino A (1999) Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system. J Neurooncol 41(2):121\u2013128. https:\/\/doi.org\/10.1023\/a:1006127624487","journal-title":"J Neurooncol"},{"issue":"3","key":"5777_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/a:1019919019497","volume":"59","author":"S Kimura","year":"2002","unstructured":"Kimura S, Yoshino A, Katayama Y, Watanabe T, Fukushima T (2002) Growth control of C6 glioma in vivo by nerve growth factor. J Neurooncol 59(3):199\u2013205. https:\/\/doi.org\/10.1023\/a:1019919019497","journal-title":"J Neurooncol"},{"issue":"5","key":"5777_CR28","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1002\/jcp.27430","volume":"234","author":"D Meco","year":"2019","unstructured":"Meco D, Di Francesco AM, Melotti L, Ruggiero A, Riccardi R (2019) Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction. J Cell Physiol 234(5):6820\u20136830. https:\/\/doi.org\/10.1002\/jcp.27430","journal-title":"J Cell Physiol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05777-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:02:37Z","timestamp":1791403357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5777"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05777-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-10466798\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Sacred Heart Catholic University in Rome (03\/07\/2012 \u2013 N. P\/659\/CE\/2012).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that the brain scan images presented in Fig.\u00a0\n                      \n                      have been entirely de-identified. As no potentially identifying information is present, specific informed consent for publication was not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"67"}}